These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16490774)

  • 1. A robust screen for inhibitors and enhancers of phosphoinositide-3 kinase (PI3K) activities by ratiometric fluorescence superquenching.
    Stankewicz C; Rininsland FH
    J Biomol Screen; 2006 Jun; 11(4):413-22. PubMed ID: 16490774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotinylated peptides for rapid identification of substrates and inhibitors of kinases and phosphatases with fluorescence superquenching.
    Wittenburg S; Stankewicz C; Rininsland F
    Assay Drug Dev Technol; 2006 Oct; 4(5):535-43. PubMed ID: 17115924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
    Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
    J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput kinase assays with protein substrates using fluorescent polymer superquenching.
    Rininsland F; Stankewicz C; Weatherford W; McBranch D
    BMC Biotechnol; 2005 May; 5():16. PubMed ID: 15927069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and application of PI3K assays for novel drug discovery.
    Yanamandra M; Mitra S; Giri A
    Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold.
    Knight ZA; Chiang GG; Alaimo PJ; Kenski DM; Ho CB; Coan K; Abraham RT; Shokat KM
    Bioorg Med Chem; 2004 Sep; 12(17):4749-59. PubMed ID: 15358300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated high content screening for phosphoinositide 3 kinase inhibition using an AKT 1 redistribution assay.
    Wolff M; Haasen D; Merk S; Kroner M; Maier U; Bordel S; Wiedenmann J; Nienhaus GU; Valler M; Heilker R
    Comb Chem High Throughput Screen; 2006 Jun; 9(5):339-50. PubMed ID: 16787147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal ion-mediated polymer superquenching for highly sensitive detection of kinase and phosphatase activities.
    Rininsland F; Xia W; Wittenburg S; Shi X; Stankewicz C; Achyuthan K; McBranch D; Whitten D
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15295-300. PubMed ID: 15494445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assays.
    Horiuchi KY; Ma H
    Methods Mol Biol; 2009; 572():161-76. PubMed ID: 20694691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and ligand-based design of mTOR and PI3-kinase inhibitors leading to the clinical candidates VS-5584 (SB2343) and SB2602.
    Poulsen A; Nagaraj H; Lee A; Blanchard S; Soh CK; Chen D; Wang H; Hart S; Goh KC; Dymock B; Williams M
    J Chem Inf Model; 2014 Nov; 54(11):3238-50. PubMed ID: 25317974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity.
    Fruman DA
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):177-80. PubMed ID: 17371231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate.
    Marks BD; Smith RW; Braun HA; Goossens TA; Christenson M; Ozers MS; Lebakken CS; Trubetskoy OV
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):73-81. PubMed ID: 15090158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin.
    Adi S; Wu NY; Rosenthal SM
    Endocrinology; 2001 Jan; 142(1):498-501. PubMed ID: 11145615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.
    Aksoy E; Vanden Berghe W; Detienne S; Amraoui Z; Fitzgerald KA; Haegeman G; Goldman M; Willems F
    Eur J Immunol; 2005 Jul; 35(7):2200-9. PubMed ID: 15940673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110alpha inhibitors.
    Kendall JD; Rewcastle GW; Frederick R; Mawson C; Denny WA; Marshall ES; Baguley BC; Chaussade C; Jackson SP; Shepherd PR
    Bioorg Med Chem; 2007 Dec; 15(24):7677-87. PubMed ID: 17869522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of LanthaScreen cellular assays for key components within the PI3K/AKT/mTOR pathway.
    Carlson CB; Robers MB; Vogel KW; Machleidt T
    J Biomol Screen; 2009 Feb; 14(2):121-32. PubMed ID: 19196698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition.
    Tolloczko B; Turkewitsch P; Al-Chalabi M; Martin JG
    J Pharmacol Exp Ther; 2004 Nov; 311(2):787-93. PubMed ID: 15194708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide 3-kinase regulates the phosphorylation of NADPH oxidase component p47(phox) by controlling cPKC/PKCdelta but not Akt.
    Yamamori T; Inanami O; Nagahata H; Kuwabara M
    Biochem Biophys Res Commun; 2004 Apr; 316(3):720-30. PubMed ID: 15033459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.